{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:08Z","timestamp":1707525128458},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,3]]},"DOI":"10.7759\/cureus.42925","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T05:06:45Z","timestamp":1691125605000},"source":"Crossref","is-referenced-by-count":0,"title":["Physical Examination as a Clue to Transthyretin Cardiac Amyloidosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Tatsuhiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyo","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13443","article-title":"Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature","volume":"8","author":"Adam RD","year":"2021","unstructured":"Adam RD, Coriu D, Jercan A, B\u0103deli\u0163\u0103 S, Popescu BA, Damy T, Jurcu\u0163 R. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail. 2021, 8:2380-96. 10.1002\/ehf2.13443","journal-title":"ESC Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318187","article-title":"Pathophysiology and therapeutic approaches to cardiac amyloidosis","volume":"128","author":"Griffin JM","year":"2021","unstructured":"Griffin JM, Rosenblum H, Maurer MS. Pathophysiology and therapeutic approaches to cardiac amyloidosis. Circ Res. 2021, 128:1554-75. 10.1161\/CIRCRESAHA.121.318187","journal-title":"Circ Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-021-00219-5","article-title":"Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review","volume":"10","author":"Rozenbaum MH","year":"2021","unstructured":"Rozenbaum MH, Large S, Bhambri R, et al.. Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review. Cardiol Ther. 2021, 10:141-59. 10.1007\/s40119-021-00219-5","journal-title":"Cardiol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney JH","year":"2013","unstructured":"Pinney JH, Smith CJ, Taube JB, et al.. Systemic amyloidosis in England: an epidemiological study. Br J Haematol. 2013, 161:525-32. 10.1111\/bjh.12286","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk RH","year":"2005","unstructured":"Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005, 112:2047-60. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.10.018","article-title":"Cardiac amyloidosis: description of a series of 143 cases","volume":"159","author":"Barge-Caballero G","year":"2022","unstructured":"Barge-Caballero G, Barge-Caballero E, L\u00f3pez-P\u00e9rez M, et al.. Cardiac amyloidosis: description of a series of 143 cases. Med Clin (Barc). 2022, 159:207-13. 10.1016\/j.medcli.2021.10.018","journal-title":"Med Clin (Barc)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller HI","year":"2017","unstructured":"Geller HI, Singh A, Alexander KM, Mirto TM, Falk RH. Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis. JAMA. 2017, 318:962-3. 10.1001\/jama.2017.9236","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcz332","article-title":"Response to: non-traumatic rupture of the biceps tendon: consider the medical causes","volume":"113","author":"Liu SZ","year":"2020","unstructured":"Liu SZ, Song A, Zhou X, Liu Y, Wang YP. Response to: non-traumatic rupture of the biceps tendon: consider the medical causes. QJM. 2020, 113:379-80. 10.1093\/qjmed\/hcz332","journal-title":"QJM"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(00)00870-5","article-title":"Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction?","volume":"15","author":"Murphy L","year":"2000","unstructured":"Murphy L, Falk RH. Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction?. Am J Cardiol. 2000, 15:244-6. 10.1016\/s0002-9149(00)00870-5","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23572","article-title":"Cardiac amyloidosis- a review of current literature for the practicing physician","volume":"44","author":"Ash S","year":"2021","unstructured":"Ash S, Shorer E, Ramgobin D, et al.. Cardiac amyloidosis- a review of current literature for the practicing physician. Clin Cardiol. 2021, 44:322-31. 10.1002\/clc.23572","journal-title":"Clin Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0650","article-title":"Third and fourth heart sounds and myocardial fibrosis in hypertrophic cardiomyopathy","volume":"82","author":"Sato Y","year":"2018","unstructured":"Sato Y, Kawasaki T, Honda S, et al.. Third and fourth heart sounds and myocardial fibrosis in hypertrophic cardiomyopathy. Circ J. 2018, 82:509-16. 10.1253\/circj.CJ-17-0650","journal-title":"Circ J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-23-0131","article-title":"Clinical significance of physical examination for hypertrophic cardiomyopathy","volume":"87","author":"Kawasaki T","year":"2023","unstructured":"Kawasaki T, Shiraishi H, Matoba S. Clinical significance of physical examination for hypertrophic cardiomyopathy. Circ J. 2023, 87:1068-74. 10.1253\/circj.CJ-23-0131","journal-title":"Circ J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171960-physical-examination-as-a-clue-to-transthyretin-cardiac-amyloidosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:15Z","timestamp":1707508995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171960-physical-examination-as-a-clue-to-transthyretin-cardiac-amyloidosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.42925","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,3]]}}}